1. Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival.
- Author
-
Li Y, Tennekoon GI, Birnbaum M, Marchionni MA, and Rutkowski JL
- Subjects
- Animals, Apoptosis drug effects, Apoptosis physiology, Cell Survival drug effects, Cell Survival physiology, Cells, Cultured, Gene Expression Regulation, Enzymologic, Phosphorylation, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins c-akt, Rats, Schwann Cells enzymology, Sciatic Nerve cytology, Signal Transduction drug effects, Transfection, bcl-Associated Death Protein, Carrier Proteins metabolism, Neuregulin-1 pharmacology, Phosphatidylinositol 3-Kinases metabolism, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins metabolism, Schwann Cells cytology, Signal Transduction physiology
- Abstract
beta-Neuregulin (betaNRG) is a potent Schwann cell survival factor that binds to and activates a heterodimeric ErbB2/ErbB3 receptor complex. We found that NRG receptor signaling rapidly activated phosphoinositide 3-kinase (PI3K) in serum-starved Schwann cells, while PI3K inhibitors markedly exacerbated apoptosis and completely blocked NRG-mediated rescue. NRG also rapidly signaled the phosphorylation of mitogen-activated protein kinase (MAPK) and the serine/threonine kinase Akt. The activation of Akt and MAPK in parallel pathways downstream from PI3K resulted in the phosphorylation of Bad at different serine residues. PI3K inhibitors that blocked NRG-mediated rescue also blocked the phosphorylation of Akt, MAPK, and Bad. However, selective inhibition of MEK-dependent Bad phosphorylation downstream from PI3K had no effect on NRG-mediated survival. Conversely, ectopic expression of wild-type Akt not only enhanced Bad phosphorylation but also enhanced autocrine- and NRG-mediated Schwann cell survival. Taken together, these results demonstrate that NRG receptor signaling through a PI3K/Akt/Bad pathway functions in Schwann cell survival., (Copyright 2001 Academic Press.)
- Published
- 2001
- Full Text
- View/download PDF